Canada markets open in 1 hour 6 minutes

Bausch Health Companies Inc. (BHC)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
5.75-0.19 (-3.20%)
At close: 04:00PM EDT
5.70 -0.05 (-0.87%)
Pre-Market: 08:05AM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close5.94
Open5.96
Bid5.21 x 1800
Ask5.90 x 4000
Day's Range5.60 - 5.97
52 Week Range4.00 - 29.59
Volume4,003,258
Avg. Volume7,466,216
Market Cap2.08B
Beta (5Y Monthly)1.35
PE Ratio (TTM)41.07
EPS (TTM)0.14
Earnings DateOct 31, 2022 - Nov 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateNov 10, 2010
1y Target Est15.35
  • The Motley Fool

    3 Top Stocks You Can Still Buy for Under $20 a Share

    Canopy Growth stock (TSX:WEED)(NASDAQ:CGC) and these two others are incredible investments to consider as we continue to move out of this market correction. The post 3 Top Stocks You Can Still Buy for Under $20 a Share appeared first on The Motley Fool Canada.

  • Zacks

    Bausch (BHC) to Appeal Regarding Xifaxan Patent Decision

    Bausch (BHC) will appeal to the U.S. Court of Appeals for the Federal Circuit regarding the patent decision for one of its key drugs Xifaxan.

  • CNW Group

    Bausch Health to Appeal XIFAXAN® Patent Decision to U.S. Court of Appeals for the Federal Circuit

    Bausch Health Companies Inc. (NYSE/TSX: BHC), and its gastroenterology business Salix Pharmaceuticals, today announced that, consistent with the company's July 28, 2022, press release, the U.S. District Court of Delaware has issued a decision in the matter of Salix Pharmaceuticals, Ltd. et al v. Norwich Pharmaceuticals, Inc. finding certain XIFAXAN® (rifaximin) 550 mg HE patents valid and infringed and certain XIFAXAN composition and IBS-D patents invalid. As previously stated, the Company will